In 2015, the Broad Institute of MIT and Harvard announced a partnership with Calico to "advance research on age-related diseases and therapeutics",[12] a further partnership also was announced with the Buck Institute for Research on Aging.[13] Also in 2015, Calico announced a partnership with QB3 based on researching the biology of aging and identifying potential therapeutics for age-related diseases[14] and one with AncestryDNA based on conducting research into the genetics of human lifespan.[15]